Cutera (NASDAQ:CUTR) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Cutera (NASDAQ:CUTR) in a research note issued to investors on Saturday. The brokerage issued a sell rating on the medical device company’s stock.

Cutera Stock Performance

Shares of NASDAQ CUTR opened at $0.44 on Friday. The firm has a market cap of $8.86 million, a P/E ratio of -0.07 and a beta of 1.32. The firm’s 50 day moving average price is $0.43 and its 200 day moving average price is $0.55. Cutera has a 1 year low of $0.28 and a 1 year high of $3.00.

Institutional Investors Weigh In On Cutera

A hedge fund recently raised its stake in Cutera stock. Geode Capital Management LLC lifted its position in shares of Cutera, Inc. (NASDAQ:CUTR) by 25.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 248,257 shares of the medical device company’s stock after buying an additional 50,046 shares during the period. Geode Capital Management LLC owned approximately 1.23% of Cutera worth $88,000 as of its most recent SEC filing. 90.70% of the stock is owned by institutional investors and hedge funds.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.